WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Simple Breathing Can Transmit TB More Effectively than Cough – New Research Debunks Old Convictions About Transmission 19/10/2021 Elaine Ruth Fletcher New research published at the opening of the 52nd Union World Conference on Lung Health has demonstrated that routine breathing can transmit tuberculosis even more effectively than coughing – in a finding that also echoes one of the signature lessons from the COVID-19 pandemic about SARS-CoV2 transmission. While large droplets jammed with bacteria produced by […] Continue reading -> South Africa Declines Sputnik COVID-19 Vaccine Approval Over HIV Infection Risk 18/10/2021 Kerry Cullinan South Africa has decided not to grant approval to Russia’s Sputnik V COVID-19 vaccine as there is a risk that it might make vaccinated men more vulnerable to HIV infection, the South African Health Products Regulatory Authority (SAHPRA) announced on Monday. SAPHRA’s caution stems from fact that Sputnik uses an Adenovirus Type 5 (Ad5) vector […] Continue reading -> WHO Estimates Africa’s COVID-19 Caseload is Seven Times Higher Than Official Count 14/10/2021 Kerry Cullinan Africa is estimated to have seven times more COVID-19 cases and three times as many deaths as officially reported, according to the World Health Organization (WHO) Africa region. This means that the continent could have around 59 million cases and 634,500 deaths. “We’re using a model to estimate the degree of under-estimation. Our analysis indicates […] Continue reading -> Six Scientists from First WHO Wuhan Mission Named to New WHO Virus Origins Investigative Group 13/10/2021 Kerry Cullinan The World Health Organization (WHO) has named 26 scientists to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), which will take forward the work of the international expert group that led an initial mission to Wuhan in January 2021, as well as investigating future pandemics. Six of the scientists are associated […] Continue reading -> India Approves COVID-19 Vaccine Covaxin for Children From the Age of Two 12/10/2021 Kerry Cullinan The Indian government’s Subject Expert Committee (SEC) has recommended the use of the country’s home-grown COVID-19 vaccine, Covaxin, for children from the age of two. This is the first vaccine in the world to be approved for such young children. Pfizer’s vaccine was recently approved for children from the age of 12 in the US. […] Continue reading -> WHO Experts Recommend Third Booster to Supplement Chinese Vaccines 11/10/2021 Kerry Cullinan The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended that people over the age of 60 who received the Chinese Sinovac and Sinopharm vaccines, should get a third shot – possibly with another vaccine. “The use of a heterologous platforms vaccine for the additional dose may also be considered based on […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> Posts navigation Older postsNewer posts
Simple Breathing Can Transmit TB More Effectively than Cough – New Research Debunks Old Convictions About Transmission 19/10/2021 Elaine Ruth Fletcher New research published at the opening of the 52nd Union World Conference on Lung Health has demonstrated that routine breathing can transmit tuberculosis even more effectively than coughing – in a finding that also echoes one of the signature lessons from the COVID-19 pandemic about SARS-CoV2 transmission. While large droplets jammed with bacteria produced by […] Continue reading -> South Africa Declines Sputnik COVID-19 Vaccine Approval Over HIV Infection Risk 18/10/2021 Kerry Cullinan South Africa has decided not to grant approval to Russia’s Sputnik V COVID-19 vaccine as there is a risk that it might make vaccinated men more vulnerable to HIV infection, the South African Health Products Regulatory Authority (SAHPRA) announced on Monday. SAPHRA’s caution stems from fact that Sputnik uses an Adenovirus Type 5 (Ad5) vector […] Continue reading -> WHO Estimates Africa’s COVID-19 Caseload is Seven Times Higher Than Official Count 14/10/2021 Kerry Cullinan Africa is estimated to have seven times more COVID-19 cases and three times as many deaths as officially reported, according to the World Health Organization (WHO) Africa region. This means that the continent could have around 59 million cases and 634,500 deaths. “We’re using a model to estimate the degree of under-estimation. Our analysis indicates […] Continue reading -> Six Scientists from First WHO Wuhan Mission Named to New WHO Virus Origins Investigative Group 13/10/2021 Kerry Cullinan The World Health Organization (WHO) has named 26 scientists to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), which will take forward the work of the international expert group that led an initial mission to Wuhan in January 2021, as well as investigating future pandemics. Six of the scientists are associated […] Continue reading -> India Approves COVID-19 Vaccine Covaxin for Children From the Age of Two 12/10/2021 Kerry Cullinan The Indian government’s Subject Expert Committee (SEC) has recommended the use of the country’s home-grown COVID-19 vaccine, Covaxin, for children from the age of two. This is the first vaccine in the world to be approved for such young children. Pfizer’s vaccine was recently approved for children from the age of 12 in the US. […] Continue reading -> WHO Experts Recommend Third Booster to Supplement Chinese Vaccines 11/10/2021 Kerry Cullinan The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended that people over the age of 60 who received the Chinese Sinovac and Sinopharm vaccines, should get a third shot – possibly with another vaccine. “The use of a heterologous platforms vaccine for the additional dose may also be considered based on […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> Posts navigation Older postsNewer posts
South Africa Declines Sputnik COVID-19 Vaccine Approval Over HIV Infection Risk 18/10/2021 Kerry Cullinan South Africa has decided not to grant approval to Russia’s Sputnik V COVID-19 vaccine as there is a risk that it might make vaccinated men more vulnerable to HIV infection, the South African Health Products Regulatory Authority (SAHPRA) announced on Monday. SAPHRA’s caution stems from fact that Sputnik uses an Adenovirus Type 5 (Ad5) vector […] Continue reading -> WHO Estimates Africa’s COVID-19 Caseload is Seven Times Higher Than Official Count 14/10/2021 Kerry Cullinan Africa is estimated to have seven times more COVID-19 cases and three times as many deaths as officially reported, according to the World Health Organization (WHO) Africa region. This means that the continent could have around 59 million cases and 634,500 deaths. “We’re using a model to estimate the degree of under-estimation. Our analysis indicates […] Continue reading -> Six Scientists from First WHO Wuhan Mission Named to New WHO Virus Origins Investigative Group 13/10/2021 Kerry Cullinan The World Health Organization (WHO) has named 26 scientists to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), which will take forward the work of the international expert group that led an initial mission to Wuhan in January 2021, as well as investigating future pandemics. Six of the scientists are associated […] Continue reading -> India Approves COVID-19 Vaccine Covaxin for Children From the Age of Two 12/10/2021 Kerry Cullinan The Indian government’s Subject Expert Committee (SEC) has recommended the use of the country’s home-grown COVID-19 vaccine, Covaxin, for children from the age of two. This is the first vaccine in the world to be approved for such young children. Pfizer’s vaccine was recently approved for children from the age of 12 in the US. […] Continue reading -> WHO Experts Recommend Third Booster to Supplement Chinese Vaccines 11/10/2021 Kerry Cullinan The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended that people over the age of 60 who received the Chinese Sinovac and Sinopharm vaccines, should get a third shot – possibly with another vaccine. “The use of a heterologous platforms vaccine for the additional dose may also be considered based on […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> Posts navigation Older postsNewer posts
WHO Estimates Africa’s COVID-19 Caseload is Seven Times Higher Than Official Count 14/10/2021 Kerry Cullinan Africa is estimated to have seven times more COVID-19 cases and three times as many deaths as officially reported, according to the World Health Organization (WHO) Africa region. This means that the continent could have around 59 million cases and 634,500 deaths. “We’re using a model to estimate the degree of under-estimation. Our analysis indicates […] Continue reading -> Six Scientists from First WHO Wuhan Mission Named to New WHO Virus Origins Investigative Group 13/10/2021 Kerry Cullinan The World Health Organization (WHO) has named 26 scientists to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), which will take forward the work of the international expert group that led an initial mission to Wuhan in January 2021, as well as investigating future pandemics. Six of the scientists are associated […] Continue reading -> India Approves COVID-19 Vaccine Covaxin for Children From the Age of Two 12/10/2021 Kerry Cullinan The Indian government’s Subject Expert Committee (SEC) has recommended the use of the country’s home-grown COVID-19 vaccine, Covaxin, for children from the age of two. This is the first vaccine in the world to be approved for such young children. Pfizer’s vaccine was recently approved for children from the age of 12 in the US. […] Continue reading -> WHO Experts Recommend Third Booster to Supplement Chinese Vaccines 11/10/2021 Kerry Cullinan The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended that people over the age of 60 who received the Chinese Sinovac and Sinopharm vaccines, should get a third shot – possibly with another vaccine. “The use of a heterologous platforms vaccine for the additional dose may also be considered based on […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> Posts navigation Older postsNewer posts
Six Scientists from First WHO Wuhan Mission Named to New WHO Virus Origins Investigative Group 13/10/2021 Kerry Cullinan The World Health Organization (WHO) has named 26 scientists to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), which will take forward the work of the international expert group that led an initial mission to Wuhan in January 2021, as well as investigating future pandemics. Six of the scientists are associated […] Continue reading -> India Approves COVID-19 Vaccine Covaxin for Children From the Age of Two 12/10/2021 Kerry Cullinan The Indian government’s Subject Expert Committee (SEC) has recommended the use of the country’s home-grown COVID-19 vaccine, Covaxin, for children from the age of two. This is the first vaccine in the world to be approved for such young children. Pfizer’s vaccine was recently approved for children from the age of 12 in the US. […] Continue reading -> WHO Experts Recommend Third Booster to Supplement Chinese Vaccines 11/10/2021 Kerry Cullinan The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended that people over the age of 60 who received the Chinese Sinovac and Sinopharm vaccines, should get a third shot – possibly with another vaccine. “The use of a heterologous platforms vaccine for the additional dose may also be considered based on […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> Posts navigation Older postsNewer posts
India Approves COVID-19 Vaccine Covaxin for Children From the Age of Two 12/10/2021 Kerry Cullinan The Indian government’s Subject Expert Committee (SEC) has recommended the use of the country’s home-grown COVID-19 vaccine, Covaxin, for children from the age of two. This is the first vaccine in the world to be approved for such young children. Pfizer’s vaccine was recently approved for children from the age of 12 in the US. […] Continue reading -> WHO Experts Recommend Third Booster to Supplement Chinese Vaccines 11/10/2021 Kerry Cullinan The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended that people over the age of 60 who received the Chinese Sinovac and Sinopharm vaccines, should get a third shot – possibly with another vaccine. “The use of a heterologous platforms vaccine for the additional dose may also be considered based on […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> Posts navigation Older postsNewer posts
WHO Experts Recommend Third Booster to Supplement Chinese Vaccines 11/10/2021 Kerry Cullinan The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended that people over the age of 60 who received the Chinese Sinovac and Sinopharm vaccines, should get a third shot – possibly with another vaccine. “The use of a heterologous platforms vaccine for the additional dose may also be considered based on […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> Posts navigation Older postsNewer posts
Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> Posts navigation Older postsNewer posts
MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> Posts navigation Older postsNewer posts
REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> Posts navigation Older postsNewer posts